![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: FIBIN |
Gene summary for FIBIN |
![]() |
Gene information | Species | Human | Gene symbol | FIBIN | Gene ID | 387758 |
Gene name | fin bud initiation factor homolog | |
Gene Alias | FIBIN | |
Cytomap | 11p14.2 | |
Gene Type | protein-coding | GO ID | GO:0007154 | UniProtAcc | Q8TAL6 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
387758 | FIBIN | P9T-E | Human | Esophagus | ESCC | 1.77e-03 | 3.15e-01 | 0.1131 |
387758 | FIBIN | P19T-E | Human | Esophagus | ESCC | 9.01e-03 | 4.50e-01 | 0.1662 |
387758 | FIBIN | P37T-E | Human | Esophagus | ESCC | 9.03e-05 | 2.34e-01 | 0.1371 |
387758 | FIBIN | P44T-E | Human | Esophagus | ESCC | 2.45e-07 | 5.67e-01 | 0.1096 |
387758 | FIBIN | P79T-E | Human | Esophagus | ESCC | 1.66e-25 | 9.44e-01 | 0.1154 |
387758 | FIBIN | ATC12 | Human | Thyroid | ATC | 8.74e-10 | 2.87e-01 | 0.34 |
387758 | FIBIN | ATC13 | Human | Thyroid | ATC | 3.59e-57 | 1.74e+00 | 0.34 |
387758 | FIBIN | ATC3 | Human | Thyroid | ATC | 1.08e-02 | 2.41e-01 | 0.338 |
387758 | FIBIN | ATC4 | Human | Thyroid | ATC | 1.21e-13 | 4.06e-01 | 0.34 |
387758 | FIBIN | ATC5 | Human | Thyroid | ATC | 1.15e-65 | 1.81e+00 | 0.34 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0048545111 | Esophagus | ESCC | response to steroid hormone | 204/8552 | 339/18723 | 4.47e-08 | 8.11e-07 | 204 |
GO:1901654111 | Esophagus | ESCC | response to ketone | 118/8552 | 194/18723 | 1.45e-05 | 1.31e-04 | 118 |
GO:001003827 | Esophagus | ESCC | response to metal ion | 208/8552 | 373/18723 | 5.02e-05 | 3.90e-04 | 208 |
GO:003196020 | Esophagus | ESCC | response to corticosteroid | 95/8552 | 167/18723 | 2.27e-03 | 9.99e-03 | 95 |
GO:005138420 | Esophagus | ESCC | response to glucocorticoid | 85/8552 | 148/18723 | 2.60e-03 | 1.11e-02 | 85 |
GO:00715487 | Esophagus | ESCC | response to dexamethasone | 26/8552 | 39/18723 | 6.63e-03 | 2.43e-02 | 26 |
GO:0048545210 | Thyroid | ATC | response to steroid hormone | 168/6293 | 339/18723 | 7.21e-10 | 1.88e-08 | 168 |
GO:190165427 | Thyroid | ATC | response to ketone | 105/6293 | 194/18723 | 2.96e-09 | 6.96e-08 | 105 |
GO:0010038210 | Thyroid | ATC | response to metal ion | 165/6293 | 373/18723 | 1.07e-05 | 1.05e-04 | 165 |
GO:005138427 | Thyroid | ATC | response to glucocorticoid | 65/6293 | 148/18723 | 5.62e-03 | 2.28e-02 | 65 |
GO:003196027 | Thyroid | ATC | response to corticosteroid | 72/6293 | 167/18723 | 6.39e-03 | 2.55e-02 | 72 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
FIBIN | SNV | Missense_Mutation | c.522N>T | p.Lys174Asn | p.K174N | Q8TAL6 | protein_coding | deleterious_low_confidence(0.01) | benign(0.349) | TCGA-B5-A0K2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Hormone Therapy | megace | SD | |
FIBIN | SNV | Missense_Mutation | novel | c.84N>A | p.Met28Ile | p.M28I | Q8TAL6 | protein_coding | tolerated_low_confidence(0.3) | probably_damaging(0.943) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
FIBIN | SNV | Missense_Mutation | novel | c.584N>T | p.Arg195Met | p.R195M | Q8TAL6 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.996) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
FIBIN | SNV | Missense_Mutation | c.544N>T | p.Gly182Trp | p.G182W | Q8TAL6 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.99) | TCGA-BK-A0CA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | taxotere | SD | |
FIBIN | SNV | Missense_Mutation | novel | c.128N>G | p.Tyr43Cys | p.Y43C | Q8TAL6 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.998) | TCGA-D1-A2G0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
FIBIN | SNV | Missense_Mutation | novel | c.529C>G | p.Leu177Val | p.L177V | Q8TAL6 | protein_coding | tolerated_low_confidence(0.33) | benign(0.031) | TCGA-EO-A3KX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
FIBIN | SNV | Missense_Mutation | c.33N>A | p.Phe11Leu | p.F11L | Q8TAL6 | protein_coding | tolerated_low_confidence(0.69) | benign(0) | TCGA-EY-A1G8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
FIBIN | SNV | Missense_Mutation | c.361N>T | p.Arg121Trp | p.R121W | Q8TAL6 | protein_coding | deleterious_low_confidence(0) | possibly_damaging(0.832) | TCGA-EY-A215-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
FIBIN | insertion | Frame_Shift_Ins | novel | c.202dupG | p.Glu68GlyfsTer72 | p.E68Gfs*72 | Q8TAL6 | protein_coding | TCGA-AP-A0LE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
FIBIN | SNV | Missense_Mutation | novel | c.212N>T | p.Gln71Leu | p.Q71L | Q8TAL6 | protein_coding | deleterious_low_confidence(0.02) | benign(0.052) | TCGA-05-4249-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |